Declining invasive pneumococcal disease mortality in the United States, 1990-2005
- PMID: 19879229
- DOI: 10.1016/j.vaccine.2009.10.121
Declining invasive pneumococcal disease mortality in the United States, 1990-2005
Abstract
PCV7 use in the U.S. has led to notable decreases in invasive pneumococcal disease (IPD). We examined PCV7 influence on IPD mortality for all age groups using National Multiple-Cause-of-Death data (1990-2005). Age-specific mortality rates were compared before and after PCV7 use. Average decreases in age-adjusted mortality rates for meningitis and septicemia accelerated post-PCV7, the greatest decline observed in septicemia-related deaths. The youngest and oldest age groups experienced large decreases in age-specific mortality rates after the introduction of PCV7. Mortality rate decline across all age groups strengthens evidence of vaccine-induced herd immunity and provides additional information for cost-benefit analyses of PCV7.
Similar articles
-
Herd immunity and pneumococcal conjugate vaccine: a quantitative model.Vaccine. 2007 Jul 20;25(29):5390-8. doi: 10.1016/j.vaccine.2007.04.088. Epub 2007 May 22. Vaccine. 2007. PMID: 17583392
-
Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.Vaccine. 2010 Mar 19;28(14):2642-7. doi: 10.1016/j.vaccine.2010.01.017. Epub 2010 Jan 20. Vaccine. 2010. PMID: 20096392
-
Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.Clin Infect Dis. 2009 Jul 15;49(2):205-12. doi: 10.1086/599827. Clin Infect Dis. 2009. PMID: 19508165
-
The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Clin Ther. 2008. PMID: 18343273 Review.
-
Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Clin Microbiol Infect. 2009. PMID: 19366362 Review.
Cited by
-
Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children.Emerg Infect Dis. 2021;27(6):1627-1636. doi: 10.3201/eid2706.204238. Emerg Infect Dis. 2021. PMID: 34013855 Free PMC article. Review.
-
Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period.Pediatrics. 2017 Nov;140(5):e20170001. doi: 10.1542/peds.2017-0001. Epub 2017 Oct 4. Pediatrics. 2017. PMID: 28978716 Free PMC article.
-
Surveillance of bacterial meningitis in the country of Georgia, 2006-2010.J Community Health. 2013 Aug;38(4):724-6. doi: 10.1007/s10900-013-9670-4. J Community Health. 2013. PMID: 23475302
-
Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Clin Microbiol Rev. 2012 Jul;25(3):409-19. doi: 10.1128/CMR.00018-12. Clin Microbiol Rev. 2012. PMID: 22763632 Free PMC article. Review.
-
Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics.Clin Infect Dis. 2016 Sep 1;63(5):619-626. doi: 10.1093/cid/ciw357. Epub 2016 Jun 9. Clin Infect Dis. 2016. PMID: 27282711 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical